Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Eguchi, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eguchi, K
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology Pages 721-722

Editorial
Editorial: Research is Long, Life is Short

RESEARCH IS LONG, LIFE IS SHORT

Medical oncologists, like a Modern Hippocrates, are struggling to study patients’ Quality-of-Life (QOL) in cancer chemotherapy. We frequently encounter scepticism of physicians, such as ‘one man’s meat is another man’s poison’, in conducting a QOL study in a large-scale multi-center trial setting. Some oncologists criticize the acquisition of QOL data as time consuming, saying ‘Good was good and bad was bad, so what? There will be nothing more than a garbage-pile of the data’. In spite of various oppositions, QOL research in cancer medicine has become one of the major scientific research fields with efforts to resolve many obstacles such as compliance of data acquisition and establishment of statistical methods for analysis.

In this issue, Han and co-workers (1) challenged to this difficult matter of the QOL assessment of chemotherapy for advanced non-small cell lung cancer in a palliative single-arm . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?